• 基本信息
    导师姓名: 徐斌 学科代码: 100210
    性别: 学科名称: 外科学
    培养单位: 附属第九人民医院 三级学科 泌尿外
    导师类型: 博士生导师 专业领域名称: 外科学 专业学位
    联系方式: chxb2004@126.com 专业领域代码: 105111
    邮编: 200011 邮箱地址: chxb2004@126.com
  • 研究方向 (点击浏览详细信息)
  • 社会任职
     
    上海医师协会泌尿外科学分会委员
    上海市医学会男科学专委会委员兼秘书兼性功能障碍学组副组长
    中华冷冻治疗学会常务理事
    上海市抗癌协会肿瘤精准治疗专家委员会委员
    中国抗癌协会介入治疗专委会肿瘤消融专家委员会副主任委员
    中国中西医结合泌尿外科学会青年委员
    中华医学会泌尿外科学分会工程学组委员
  • 科研项目
    项目编号项目名称课题来源起止年月批准经费承担职责
    2022sbr-xb氩气刀免缝合与常规缝合技术对肾部分切除术后肾功能的影响:一项多中心、开放标签随机对照研究上海交通大学医学院 2023-01~2025-12 100万元  课题负责人
    M-017The mechanism of DLX1 promoting the castration resistance of prostate cancer by regulating androgen receptor国家自然科学基金-中德科学中心中德合作交流项目 2021-01~2023-12 150万元  课题负责人
    82072846DLX1靶向调控雄激素受体在前列腺癌去势抵抗机制中的研究国家自然科学基金委员会-面上项目 2021-01~2024-12 55万元  课题负责人
    SHWSRS(2021)_099上海市“医苑新星”杰出青年医学人才研究基金上海市卫健委、市医药卫生发展基金会 2021-01~2023-12 20万元  课题负责人
    19DZ2204000肾肿瘤氩氦刀冷冻消融标准研究上海市科委-技术标准项目 2019-09~2022-08 30万元  课题负责人
    19DZ2320600健康人生泌尿生殖为宝,微创引领医疗开门见山上海市科委-科普集市项目 2019-08~2020-10 60万元  课题负责人
    201818042基于医学影像的混合现实手术导航系统在肾癌的精准保肾手术中的应用研究上海交通大学医学院附属第九人民医院-“交叉”研究基金 2019-01~2021-12 30万元  课题负责人
    2017LC002家族遗传性肾癌精准基因诊断及精准治疗的系统性研究上海交通大学医学院-高峰学科项目 2017-07~2017-11 50万元  课题负责人
    15QA1404900血小板活化因子及其受体通路在去势耐受型前 列腺癌形成中的作用研究上海市科委-科技启明星 2015-04~2018-03 20万元  课题负责人
    81472398AR及Wnt/ß-catenin通路调控血小板活化因子参与去势耐受型前列腺癌形成及其机制研究国家自然科学基金委员会-面上项目 2015-01~2018-12 68万元  课题负责人
  • 学术论文
    作者论文标题期刊名出版年卷期页码
    Chao Fang, Gaozhe Xiao, Taixia Wang, Li Song, Bo Peng,, Kun Zhang  Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy  Research (Wash D C).   2023  2023;6:0108. 
    Liang L, Zheng D, Lu C, Xi Q, Bao H, Li W, Gu Y, Mao Y,, Gu X.  Exosomes derived from miR-301a-3p-overexpressing adipose-derived mesenchymal stem cells reverse hypoxia-induced erectile dysfunction in rat models  Stem Cell Res Ther,  2021  12(1): 87 
    Wang J, Zou Y, Du B, Li W, Yu G, Li L, Zhou L, Gu X, Song S, Liu Y, Zhou W,, Wang Z.   SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling  Cell Death Dis  2021  12(7): 672. 
    Zhou L,, Liu Y, Wang Z.  Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer  Oncoimmunology  2021  10(1): 1915574 
    Wang R, Wu Y, Yu J, Yang G, Yi H,  Plasma Messenger RNAs Identified Through Bioinformatics Analysis are Novel, Non-Invasive Prostate Cancer Biomarkers  OncoTargets and therapy  2020  13(541-548. 
    Han C,, Zhou L, Li L, Lu C, Yu G P, Liu Y S  LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis  OncoTargets and therapy  2020  13(10185-10196. 
    Mao Y, Li W, Hua B, Gu X, Pan W, Chen Q,, Lu C, Wang Z.  Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p  Front Cell Dev Biol  2020  8(602707. 
    Tan H, Hou N, Liu Y, Liu B, Cao W, Zheng D, Li W, Liu Y,, Wang Z, Cui D.  CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer  Nanomedicine  2020  27(102192. 
    Han C, Yu G, Mao Y, Song S, Li L, Zhou L, Wang Z, Liu Y, Li M,  LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production  PLoS One  2020  15(11): e0240801 
    Shangqing Song, Manmei Long, Guopeng Yu, Yajun Cheng, Qing Yang, Jiayi Liu, Yiwei Wang, Jiayan Sheng, Linhui Wang, Zhong Wang,  Urinary exosome miR‐30c‐5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.  Journal of Cellular and Molecular Medicine  2019  Accept 
    , 宋尚卿, 吴震杰, 刘冰, 杨庆, 肖亮, 程亚军, 于国鹏, 李龙, 王忠, 王林辉, 孙颖浩  肾癌冷冻消融术64例经验总结  中华泌尿外科杂志  2018  39(6): 422-427. 
    Cheng Yajun, Tang yuan, Wang zhong ,  Investigation of the molecular mechanisms underlying postoperative recurrence in prostate cancer by gene expression profiling  Experimental and Therapeutic Medicine  2018  15: 761-768 
    李文智, 李龙, 于国鹏, 王忠,  氩气刀免缝合技术在肾肿瘤肾部分切除术中的应用及优势  上海交通大学学报(医学版)  2018  38(7): 781-783 
    Yu G, Zhang K, Li W, Li L, Zhao Y, Wang Y, Xu M, Da J, Dong G, Wang Z,  Unilateral Renal Tumor Cryoablation and Contralateral Radical Nephrectomy of Bilateral Renal Tumors by Transumbilical 3D Multichannel Laparoendoscopic Single-Site Surgery  J Endourol Case Rep  2018  4(1): 53-58 
    , Yajun C, Chen Y, Xiaosa L, Xiao W, Jia C, Zhong W.  Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation  Oncotarget  2017  2017 Jul 12. doi: 10.18632/oncotarget.19210. 
    , Peng Y, Zhang W, Li L, Liu M, Gao X, Sun Y.  Retrograde intrarenal surgery for the treatment of renal stones: is fluoroscopy-free technique achievable?  Urolithiasis  2015  43(3):265-270 
    , Tang G, Xiao C, Wang L, Yang Q, Sun Y.   Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers.  Int J Clin Exp Pathol  2014  7(6):2883-2293 
    , Gao L, Wang L, Tang G, He M, Yu Y, Ni X, Sun Y.  Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers  Br J Cancer  2013  109(5):1279-1286. 
    , Friedlander JI, Chuang KW, Yalin S, Ghiraldi E, Ma J, Okhunov Z, Okeke Z, Smith AD.  Predictive factors for intraoperative balloon dilation in semirigid ureteroscopic lithotripsy  J Endourol  2012  26(8):988-991 
    , Roy OP, Ghiraldi E, Manglik N, Liang T, Vira M, Kavoussi LR.  Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours  BJU Int  2012  110(11 Pt B):E514-9. 
    , Bo Y, Dan S, Okhunov Z, Ghiraldi E, Huiqing W, Friedlander J, Liang X, Yinghao S, Kavoussi LR.  A novel transvesical port for natural orifice translumenal endoscopic surgery.  J Endourol  2012  26(3):219-223. 
    , Jiatao J, Huamao Y, Jianguo H, Bing L, Yinghao S.  Removal of a long PVC pipe strangulated in the penis by hot-melt method.  J Sex Med  2011  8(2):627-630 
    , Qing Y, Linhui W, Li G, Yinghao S.  Adrenal incidentalomas: experience from a retrospective study in a Chinese population.   Urol Oncol.  2011  29(3):270-274. 
    ,Xiao C, Ye H, Yang Q, Wang L, Sun YH.  Experience with adrenal schwannoma in a Chinese population of six patients  J Endocrinol Invest  2011  34(6):417-421 
    , Yang B, Zeng Q, Altunrende F, Wang H, Xiao L, Wang L, Xu C, Sun Y.  A specialized course of basic skills training for single-port laparoscopic surgery.  Surgery.  2011  149(6):766-775 
    ,Tang L, Gao X, Hou J, Zhang Z, Xu C, Wang L, Sun Y.  Placement of ureteral stent after uncomplicated ureteroscopy: do we really need it?  Urology  2011  78(6):1248-1256. 
    , Wang LH, Liu Q, Chen W, Yang Q, Wang ZX, Sun YH.   Identification of nuclear localization sequence of CXCR4 in renal cell carcinoma by constructing expression plasmids of different deletants.  Plasmid.  2010  63(1):68-72. 
    ,Qing Y, Jian W, Li G, Linhui W, Bing L, Huiqing W, Yinghao S.  Adrenal ganglioneuromas: a 10-year experience in a Chinese population.  Surgery  2010  147(6):854-860. 
    , Sun Y, Tang G, Xu C, Wang L, Zhang Y, Ji J.  Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor.  cancer letter  2009  278(2):220-229.